Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Eculizumab approved by FDA to treat atypical hemolytic uremic syndrome. |
 |
 |
| Medical News Today: The U.S. Food and Drug Administration approved Soliris (eculizumab) to treat individuals with atypical hemolytic Uremic Syndrome (aHUS). aHUS is a rare and chronic blood disease that can result in kidney (renal) failure and is linked with an increased risk of death and stroke. |
